EV/EBITDA:
-8.34+0.01(+0.12%)Summary
- As of today, AMLX EV/EBITDA is -8.34, with a rise of +0.01 (+0.12%) during the most recent trading session on November 28, 2025.
- Over the past year, AMLX EV/EBITDA has dropped by -7.69 (-1183.08%).
- AMLX EV/EBITDA is now -134.68% below its all-time high of 24.05.
Performance
AMLX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AMLX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +0.1% | -0.2% | -0.1% |
| 1M1 Month | -5.8% | +5.9% | +4.6% |
| 3M3 Months | -146.0% | +96.5% | +59.0% |
| 6M6 Months | -672.2% | +482.7% | +212.7% |
| YTDYTD | -2775.9% | +1439.5% | +296.3% |
| 1Y1 Year | -1183.1% | +708.6% | +161.0% |
| 5Y5 Years | - | - | - |
AMLX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -6.38 | -30.7% | -8.35 | +0.1% |
| 3M | 3-Month | -3.37 | -147.5% | -9.08 | +8.2% |
| 6M | 6-Month | -1.08 | -672.2% | -9.08 | +8.2% |
| 1Y | 1-Year | -0.13 | -6315.4% | -9.08 | +8.2% |
| 3Y | 3-Year | 24.05 | -134.7% | -132.60 | +93.7% |
| 5Y | 5-Year | 24.05 | -134.7% | -132.60 | +93.7% |
| All-Time | All-Time | 24.05 | -134.7% | -132.60 | +93.7% |
AMLX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -8.34(-2775.9%) |
| 2024 | -0.29(-101.8%) |
| Date | Value |
|---|---|
| 2023 | 15.78(+249.7%) |
| 2022 | -10.54 |
FAQ
- What is Amylyx Pharmaceuticals, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Amylyx Pharmaceuticals, Inc.?
- What is AMLX EV/EBITDA year-to-date change?
- What is Amylyx Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
What is Amylyx Pharmaceuticals, Inc. EV/EBITDA?
The current EV/EBITDA of AMLX is -8.34
What is the all-time high EV/EBITDA for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high EV/EBITDA is 24.05
What is AMLX EV/EBITDA year-to-date change?
Amylyx Pharmaceuticals, Inc. EV/EBITDA has changed by -8.05 (-2775.86%) since the beginning of the year
What is Amylyx Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
Over the past year, AMLX EV/EBITDA has changed by -7.69 (-1183.08%)